PBAX NASDAQ
Phoenix Biotech Acquisition Corp.
1W: -16.8%
1M: -47.5%
3M: -46.2%
1Y: -44.3%
$5.85
Last traded 2024-02-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$16M
+0.0% ▲
Net Income
-$11M
+0.0% ▲
EPS (Diluted)
$-0.22
+0.0% ▲
EBITDA
-$16M
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $255K | $0 |
| Gross Margin | — | — | — |
| R&D Expenses | $0 | $0 | $7M |
| SG&A Expenses | $252K | $3M | $9M |
| Operating Expenses | $332K | $3M | $16M |
| Operating Income | -$332K | -$3K | -$16M |
| Operating Margin | — | — | — |
| Interest Expense | $0 | $0 | $0 |
| Income Before Tax | -$332K | -$69K | -$11M |
| Tax Expense | -$17K | $599K | $0 |
| Net Income | -$316K | -$668K | -$11M |
| Net Margin | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.01 | $-0.22 |
| EBITDA | -$332K | -$6M | -$16M |
| Shares Outstanding | 69M | 67M | 50M |